{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:55:12Z","timestamp":1781538912762,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2021QH046"],"award-info":[{"award-number":["ZR2021QH046"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971088"],"award-info":[{"award-number":["81971088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2018MC008"],"award-info":[{"award-number":["ZR2018MC008"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Development Plan of Medical and Health Science and Technology in Shandong Province","award":["202104020535"],"award-info":[{"award-number":["202104020535"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04454-x","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:02:23Z","timestamp":1781532143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BUB1B is a novel prognostic-related biomarker and correlated with immune infiltrates in lung adenocarcinoma"],"prefix":"10.1007","author":[{"given":"Zhaochun","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaopeng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6298-6192","authenticated-orcid":false,"given":"Shuhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"3","key":"4454_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4454_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4454_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/20503121221142171","volume":"10","author":"K Kadeetham","year":"2022","unstructured":"Kadeetham K, Ngodngamthaweesuk M, Kantathut N. Overall 5-year survival rate and disease-free survival after segmentectomy versus lobectomy in patients with non-small cell lung cancer. SAGE Open Med. 2022;10:20503121221142171.","journal-title":"SAGE Open Med"},{"issue":"1","key":"4454_CR4","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s12672-025-03690-x","volume":"16","author":"GQ Song","year":"2025","unstructured":"Song GQ, Wu YY, He TL, Ji KJ, Duan YM, Zhang JW, et al. Identification and validation of prognostic genes for lung adenocarcinoma prognosis based on PANoptosis-related genes. Discover oncology. 2025;16(1):1935.","journal-title":"Discover oncology"},{"issue":"1","key":"4454_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41392-022-01130-8","volume":"7","author":"C Wang","year":"2022","unstructured":"Wang C, Yu Q, Song T, Wang Z, Song L, Yang Y, et al. The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing. Signal Transduct Target Ther. 2022;7(1):289.","journal-title":"Signal Transduct Target Ther"},{"key":"4454_CR6","doi-asserted-by":"crossref","unstructured":"Koyuncu D, Sharma U, Goka ET, Lippman ME. Spindle assembly checkpoint gene BUB1B is essential in breast cancer cell survival. 2021;185(2):331-41.","DOI":"10.1007\/s10549-020-05962-2"},{"issue":"1","key":"4454_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ijc.31718","volume":"144","author":"G Simonetti","year":"2019","unstructured":"Simonetti G, Bruno S, Padella A, Tenti E, Martinelli G. Aneuploidy: cancer strength or vulnerability? Int J Cancer. 2019;144(1):8\u201325.","journal-title":"Int J Cancer"},{"issue":"6","key":"4454_CR8","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.cell.2018.08.027","volume":"174","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum SF, Cantley LC. The multifaceted role of chromosomal instability in cancer and its microenvironment. Cell. 2018;174(6):1347\u201360.","journal-title":"Cell"},{"key":"4454_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.810793","volume":"12","author":"E Balzano","year":"2021","unstructured":"Balzano E, Di Tommaso E, Antoccia A, Pelliccia F, Giunta S. Characterization of chromosomal instability in glioblastoma. Front Genet. 2021;12:810793.","journal-title":"Front Genet"},{"key":"4454_CR10","doi-asserted-by":"crossref","unstructured":"W\u00f6rmann SM, Zhang A, Thege FI, Cowan RW. APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis. 2021;2(12):1338\u201356.","DOI":"10.1038\/s43018-021-00268-8"},{"key":"4454_CR11","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05269","volume":"4","author":"K Overlack","year":"2015","unstructured":"Overlack K, Primorac I, Vleugel M, Krenn V, Maffini S, Hoffmann I, et al. A molecular basis for the differential roles of Bub1 and BubR1 in the spindle assembly checkpoint. Elife. 2015;4:e05269.","journal-title":"Elife"},{"key":"4454_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/B978-0-12-407694-5.00006-7","volume":"306","author":"RE Karess","year":"2013","unstructured":"Karess RE, Wassmann K, Rahmani Z. New insights into the role of BubR1 in mitosis and beyond. Int Rev Cell Mol Biol. 2013;306:223\u201373.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"4","key":"4454_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.tibs.2022.01.004","volume":"47","author":"S Elowe","year":"2022","unstructured":"Elowe S, Bolanos-Garcia VM. The spindle checkpoint proteins BUB1 and BUBR1: (SLiM)ming down to the basics. Trends Biochem Sci. 2022;47(4):352\u201366.","journal-title":"Trends Biochem Sci"},{"key":"4454_CR14","doi-asserted-by":"crossref","unstructured":"Tang X, Guo M, Ding P, Deng Z, Ke M, Yuan Y, et al. BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability. 2021;6(1):361.","DOI":"10.1038\/s41392-021-00746-6"},{"key":"4454_CR15","doi-asserted-by":"publisher","DOI":"10.3892\/or.2025.8980","author":"X Luo","year":"2025","unstructured":"Luo X, Wei Y, Lin H, Xiao N, Zhao W. BUB1B promotes homologous recombination\u2011mediated DNA damage repair in breast cancer cells through the PI3K\/AKT signaling pathway. Oncol Rep. 2025. https:\/\/doi.org\/10.3892\/or.2025.8980.","journal-title":"Oncol Rep"},{"issue":"7","key":"4454_CR16","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2807151","volume":"28","author":"D Mishra","year":"2023","unstructured":"Mishra D, Mishra A, Rai SN, Singh SK, Vamanu E, Singh MP. In silico insight to identify potential inhibitors of BUB1B from mushroom bioactive compounds to prevent breast cancer metastasis. Frontiers in bioscience (Landmark edition). 2023;28(7):151.","journal-title":"Frontiers in bioscience (Landmark edition)"},{"issue":"9","key":"4454_CR17","doi-asserted-by":"publisher","first-page":"12395","DOI":"10.18632\/aging.202944","volume":"13","author":"Z Long","year":"2021","unstructured":"Long Z, Wu T, Tian Q, Carlson LA, Wang W, Wu G. Expression and prognosis analyses of BUB1, BUB1B and BUB3 in human sarcoma. Aging Albany NY. 2021;13(9):12395\u2013409.","journal-title":"Aging Albany NY"},{"issue":"4","key":"4454_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000512446","volume":"99","author":"Y Sekino","year":"2021","unstructured":"Sekino Y, Han X, Kobayashi G, Babasaki T, Miyamoto S, Kobatake K, et al. BUB1B overexpression is an independent prognostic marker and associated with CD44, p53, and PD-L1 in renal cell carcinoma. Oncology. 2021;99(4):240\u201350.","journal-title":"Oncology"},{"issue":"5","key":"4454_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s13205-025-04297-3","volume":"15","author":"S Modanwal","year":"2025","unstructured":"Modanwal S, Mulpuru V, Mishra A. Transcriptomic signatures of prostate cancer progression: a comprehensive RNA-seq study. 3 Biotech. 2025;15(5):135.","journal-title":"3 Biotech"},{"issue":"3","key":"4454_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.21037\/cco-23-151","volume":"13","author":"MA Hossen","year":"2024","unstructured":"Hossen MA, Reza MS, Rana MM, Hossen MB, Shoaib M, Mollah MNH, et al. Identification of most representative hub-genes for diagnosis, prognosis, and therapies of hepatocellular carcinoma. Chin Clin Oncol. 2024;13(3):32.","journal-title":"Chin Clin Oncol"},{"key":"4454_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13061142","author":"D Mishra","year":"2023","unstructured":"Mishra D, Mishra A. Demystifying the role of prognostic biomarkers in breast cancer through integrated transcriptome and pathway enrichment analyses. Diagnostics Basel. 2023. https:\/\/doi.org\/10.3390\/diagnostics13061142.","journal-title":"Diagnostics Basel"},{"issue":"1","key":"4454_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41419-020-03234-x","volume":"12","author":"CY Jiao","year":"2021","unstructured":"Jiao CY, Feng QC, Li CX, Wang D, Han S, Zhang YD, et al. BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK\/c-Jun pathways. Cell Death Dis. 2021;12(1):63.","journal-title":"Cell Death Dis"},{"issue":"21","key":"4454_CR23","doi-asserted-by":"publisher","first-page":"8159","DOI":"10.1002\/cam4.3411","volume":"9","author":"J Qiu","year":"2020","unstructured":"Qiu J, Zhang S, Wang P, Wang H, Sha B, Peng H, et al. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway. Cancer Med. 2020;9(21):8159\u201372.","journal-title":"Cancer Med"},{"issue":"1","key":"4454_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06243-6","volume":"23","author":"F Zhao","year":"2025","unstructured":"Zhao F, Chen M, Wu T, Ji M, Li F. Integration of single-cell and bulk RNA sequencing to identify a distinct tumor stem cells and construct a novel prognostic signature for evaluating prognosis and immunotherapy in LUAD. J Transl Med. 2025;23(1):222.","journal-title":"J Transl Med"},{"key":"4454_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1572757","volume":"16","author":"H Zhou","year":"2025","unstructured":"Zhou H, Chen Z, Gao S, Lian C, Hu J, Lu J, et al. GPR65 is a novel immune biomarker and regulates the immune microenvironment in lung adenocarcinoma. Front Immunol. 2025;16:1572757.","journal-title":"Front Immunol"},{"key":"4454_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2019.101896","volume":"80","author":"E Le Rhun","year":"2019","unstructured":"Le Rhun E, Preusser M, Roth P, Reardon DA, van den Bent M, Wen P, et al. Molecular targeted therapy of glioblastoma. Cancer Treat Rev. 2019;80:101896.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"4454_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-01056-z","volume":"31","author":"MP Silva","year":"2024","unstructured":"Silva MP, Ferreira LT, Br\u00e1s NF, Torres L, Brand\u00e3o A, Pinheiro M, et al. BUB1B monoallelic germline variants contribute to prostate cancer predisposition by triggering chromosomal instability. J Biomed Sci. 2024;31(1):74.","journal-title":"J Biomed Sci"},{"key":"4454_CR28","doi-asserted-by":"crossref","unstructured":"Dong S, Huang F, Zhang H, Chen Q. Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma. 2019;39(2).","DOI":"10.1042\/BSR20182306"},{"key":"4454_CR29","doi-asserted-by":"crossref","unstructured":"Zhuang L, Yang Z. Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients. 2018;2018:7897346.","DOI":"10.1155\/2018\/7897346"},{"issue":"1","key":"4454_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1530\/EJE-11-0806","volume":"166","author":"MC Fragoso","year":"2012","unstructured":"Fragoso MC, Almeida MQ, Mazzuco TL, Mariani BM, Brito LP, Gon\u00e7alves TC, et al. Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients. Eur J Endocrinol. 2012;166(1):61\u20137.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"4454_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1089\/bio.2015.29031.hmm","volume":"13","author":"LJ Carithers","year":"2015","unstructured":"Carithers LJ, Moore HM. The genotype-tissue expression (GTEx) project. Biopreserv Biobank. 2015;13(5):307\u20138.","journal-title":"Biopreserv Biobank"},{"issue":"21","key":"4454_CR32","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Can Res. 2017;77(21):e108\u201310.","journal-title":"Can Res"},{"issue":"W1","key":"4454_CR33","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98-w102.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"4454_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082241","volume":"8","author":"B Gy\u0151rffy","year":"2013","unstructured":"Gy\u0151rffy B, Surowiak P, Budczies J, L\u00e1nczky A. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS ONE. 2013;8(12):e82241.","journal-title":"PLoS ONE"},{"issue":"1","key":"4454_CR35","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248\u201362.","journal-title":"Cell Rep"},{"key":"4454_CR36","doi-asserted-by":"crossref","unstructured":"Wei J, Huang K. Characterization of Glycolysis-Associated Molecules in the Tumor Microenvironment Revealed by Pan-Cancer Tissues and Lung Cancer Single Cell Data. 2020;12(7).","DOI":"10.3390\/cancers12071788"},{"issue":"D1","key":"4454_CR37","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"4454_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1053\/j.sult.2018.11.009","volume":"40","author":"BD Hutchinson","year":"2019","unstructured":"Hutchinson BD, Shroff GS, Truong MT, Ko JP. Spectrum of lung adenocarcinoma. Semin Ultrasound CT MRI. 2019;40(3):255\u201364.","journal-title":"Semin Ultrasound CT MRI"},{"issue":"2","key":"4454_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3402","volume":"15","author":"LA Habel","year":"2013","unstructured":"Habel LA, Sakoda LC, Achacoso N, Ma XJ, Erlander MG, Sgroi DC, et al. HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease. Breast Cancer Res. 2013;15(2):R24.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"4454_CR40","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.canlet.2007.03.021","volume":"254","author":"M Scintu","year":"2007","unstructured":"Scintu M, Vitale R, Prencipe M, Gallo AP, Bonghi L, Valori VM, et al. Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma. Cancer Lett. 2007;254(2):298\u2013307.","journal-title":"Cancer Lett"},{"key":"4454_CR41","first-page":"2211","volume":"9","author":"X Fu","year":"2016","unstructured":"Fu X, Chen G, Cai ZD, Wang C, Liu ZZ, Lin ZY, et al. Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer. OncoTargets Ther. 2016;9:2211\u201320.","journal-title":"OncoTargets Ther"},{"key":"4454_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052061","author":"Z Hao","year":"2025","unstructured":"Hao Z, An F, Zhang W, Zhu X, Meng S, Zhao B. A comprehensive analysis revealing BUB1B as a potential prognostic and immunological biomarker in Lung Adenocarcinoma. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26052061.","journal-title":"Int J Mol Sci"},{"key":"4454_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.732841","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Li H, Zhang C, Zhang C, Jiang L, Wang H, et al. Identification of a gene signature closely related to immunosuppressive tumour microenvironment predicting prognosis of patients in EGFR mutant lung adenocarcinoma. Front Oncol. 2021;11:732841.","journal-title":"Front Oncol"},{"issue":"1","key":"4454_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-36364-x","volume":"16","author":"CY Sun","year":"2026","unstructured":"Sun CY, Yu X, Deng LQ, Han YJ, He LJ, Yan HY. Translational evaluation of BUB1B as a precision medicine biomarker for hepatocellular carcinoma. Sci Rep. 2026;16(1):5301.","journal-title":"Sci Rep"},{"key":"4454_CR45","doi-asserted-by":"crossref","unstructured":"Wu J, Li L, Zhang H, Zhao Y, Zhang H, Wu S, et al. A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma. 2021;40(26):4413-24.","DOI":"10.1038\/s41388-021-01853-y"},{"key":"4454_CR46","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","volume":"470","author":"X Lei","year":"2020","unstructured":"Lei X, Lei Y, Li JK, Du WX, Li RG, Yang J, et al. Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy. Cancer Lett. 2020;470:126\u201333.","journal-title":"Cancer Lett"},{"issue":"1","key":"4454_CR47","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12957-025-04070-z","volume":"23","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Wu C, Li Q, Hu Y, Li Y, Wu Z, et al. HROB is a novel prognostic biomarker correlated with immune cell infiltration and tumor progression in lung adenocarcinoma. World journal of surgical oncology. 2025;23(1):415.","journal-title":"World journal of surgical oncology"},{"issue":"11","key":"4454_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24022","volume":"35","author":"R Deng","year":"2021","unstructured":"Deng R, Li J, Zhao H, Zou Z, Man J, Cao J, et al. Identification of potential biomarkers associated with immune infiltration in papillary renal cell carcinoma. J Clin Lab Anal. 2021;35(11):e24022.","journal-title":"J Clin Lab Anal"},{"key":"4454_CR49","doi-asserted-by":"crossref","unstructured":"Chen J, Liao Y. Prognostic and clinicopathological value of BUB1B expression in patients with lung adenocarcinoma: a meta-analysis. 2021; 21(7): 795\u2013803.","DOI":"10.1080\/14737140.2021.1908132"},{"issue":"3\u20134","key":"4454_CR50","doi-asserted-by":"publisher","first-page":"106","DOI":"10.18632\/genesandcancer.53","volume":"6","author":"H Chen","year":"2015","unstructured":"Chen H, Lee J, Kljavin NM, Haley B, Daemen A, Johnson L, et al. Requirement for BUB1B\/BUBR1 in tumor progression of lung adenocarcinoma. Genes Cancer. 2015;6(3\u20134):106\u201318.","journal-title":"Genes Cancer"},{"issue":"3","key":"4454_CR51","first-page":"236","volume":"39","author":"Q Zeng","year":"2024","unstructured":"Zeng Q, Zhang S, He L, Fu Q, Liao L, Chen L, et al. Knockdown of BUB1B Inhibits the Proliferation, Migration, and Invasion of Colorectal Cancer by Regulating the JNK\/c-Jun Signaling Pathway. Cancer Biother Radiopharm. 2024;39(3):236\u201346.","journal-title":"Cancer Biother Radiopharm"},{"key":"4454_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102334","volume":"54","author":"Z Qin","year":"2025","unstructured":"Qin Z, Ye F, Wang J, Jiang J, Zhang X, Li H, et al. BUB1B promotes cisplatin resistance in gastric cancer via Rad51-mediated DNA damage repair. Translational oncology. 2025;54:102334.","journal-title":"Translational oncology"},{"issue":"6","key":"4454_CR53","first-page":"3367","volume":"38","author":"Q Ma","year":"2017","unstructured":"Ma Q, Liu Y, Shang L, Yu J, Qu Q. The FOXM1\/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma. Oncol Rep. 2017;38(6):3367\u201375.","journal-title":"Oncol Rep"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04454-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04454-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04454-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:05:49Z","timestamp":1781535949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04454-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":53,"alternative-id":["4454"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04454-x","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}